16091734 |
FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies
Gilliland, DG,
Cohen, S,
Huntly, BJ,
Griffin, J,
Duclos, N,
Fabbro, D,
Okabe, R,
Moore, S,
Mitsiades, CS,
Lee, BH,
Chen, J,
Kutok, J,
Adelsperger, J,
Anderson, KC,
Coburn, A,
Williams, I
|
Oncogene |
2005 |
15598814 |
CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma
Wei, E,
Wiesmann, M,
Trudel, S,
Chang, H,
Chen, C,
Stewart, AK,
Li, ZH,
Heise, C,
Reece, D
|
Blood |
2005 |
14871245 |
Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma
Trudel, S,
Pollett, JB,
Wen, XY,
Paterson, JL,
Masih-Khan, E,
Chang, H,
Stewart, AK,
Li, Z
|
Br J Haematol |
2004 |
19381019 |
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
Stephan, JP,
Dornan, D,
Stinson, S,
Wiesmann, C,
Du, X,
Wu, P,
Qing, J,
Ashkenazi, A,
Wu, Y,
Tien, J,
French, D,
Totpal, K,
Chan, P,
Chen, Y,
Marsters, S,
Ross, S,
Li, H,
Wang, QR,
Stawicki, S
|
J Clin Invest |
2009 |
18757432 |
Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer
Delattre, O,
Pierron, G,
Reyal, F,
Stransky, N,
Bernard-Pierrot, I,
Radvanyi, F,
Vallot, C,
Gruel, N,
Raynal, V,
Vincent-Salomon, A
|
Cancer Res |
2008 |
14715624 |
Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma
Trudel, S,
Chesi, M,
Bergsagel, PL,
Farooqi, Y,
Affer, M,
Robbiani, DF,
Ely, S
|
Blood |
2004 |
15029211 |
Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074
Rahemtulla, A,
Grand, EK,
Chase, AJ,
Cross, NC,
Heath, C
|
Leukemia |
2004 |
16467200 |
The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells
Wei, E,
Yayon, A,
Trudel, S,
Rom, E,
Chumakov, I,
Chang, H,
Li, ZH,
Stewart, AK,
Liang, SB,
Singer, Y,
Kotzer, S
|
Blood |
2006 |